Ad is loading...
ABCL
Price
$2.72
Change
+$0.05 (+1.87%)
Updated
Nov 21 closing price
95 days until earnings call
IGMS
Price
$8.89
Change
-$0.88 (-9.01%)
Updated
Nov 21 closing price
125 days until earnings call
Ad is loading...

ABCL vs IGMS

Header iconABCL vs IGMS Comparison
Open Charts ABCL vs IGMSBanner chart's image
AbCellera Biologics
Price$2.72
Change+$0.05 (+1.87%)
Volume$1.43M
CapitalizationN/A
IGM Biosciences
Price$8.89
Change-$0.88 (-9.01%)
Volume$417.06K
CapitalizationN/A
ABCL vs IGMS Comparison Chart
Loading...
ABCL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
IGMS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
ABCL vs. IGMS commentary
Nov 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABCL is a Sell and IGMS is a StrongSell.

COMPARISON
Comparison
Nov 22, 2024
Stock price -- (ABCL: $2.72 vs. IGMS: $8.89)
Brand notoriety: ABCL and IGMS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABCL: 68% vs. IGMS: 122%
Market capitalization -- ABCL: $803.4M vs. IGMS: $580.67M
ABCL [@Biotechnology] is valued at $803.4M. IGMS’s [@Biotechnology] market capitalization is $580.67M. The market cap for tickers in the [@Biotechnology] industry ranges from $463.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABCL’s FA Score shows that 0 FA rating(s) are green whileIGMS’s FA Score has 0 green FA rating(s).

  • ABCL’s FA Score: 0 green, 5 red.
  • IGMS’s FA Score: 0 green, 5 red.
According to our system of comparison, ABCL is a better buy in the long-term than IGMS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABCL’s TA Score shows that 6 TA indicator(s) are bullish while IGMS’s TA Score has 4 bullish TA indicator(s).

  • ABCL’s TA Score: 6 bullish, 4 bearish.
  • IGMS’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, ABCL is a better buy in the short-term than IGMS.

Price Growth

ABCL (@Biotechnology) experienced а -1.45% price change this week, while IGMS (@Biotechnology) price change was -11.98% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.74%. For the same industry, the average monthly price growth was -7.78%, and the average quarterly price growth was +1.53%.

Reported Earning Dates

ABCL is expected to report earnings on Feb 25, 2025.

IGMS is expected to report earnings on Mar 27, 2025.

Industries' Descriptions

@Biotechnology (-3.74% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABCL($803M) has a higher market cap than IGMS($581M). IGMS YTD gains are higher at: 6.980 vs. ABCL (-52.364). ABCL has higher annual earnings (EBITDA): -202.4M vs. IGMS (-225.78M). ABCL has more cash in the bank: 643M vs. IGMS (219M). IGMS has less debt than ABCL: IGMS (45.9M) vs ABCL (71.4M). ABCL has higher revenues than IGMS: ABCL (33M) vs IGMS (2.92M).
ABCLIGMSABCL / IGMS
Capitalization803M581M138%
EBITDA-202.4M-225.78M90%
Gain YTD-52.3646.980-750%
P/E RatioN/AN/A-
Revenue33M2.92M1,131%
Total Cash643M219M294%
Total Debt71.4M45.9M156%
TECHNICAL ANALYSIS
Technical Analysis
ABCLIGMS
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
88%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
88%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 26 days ago
75%
Bullish Trend 3 days ago
83%
Declines
ODDS (%)
Bearish Trend 8 days ago
86%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
84%
Aroon
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Ad is loading...
ABCL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
IGMS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
YOVIX16.940.30
+1.80%
Yorktown Small-Cap Institutional
JNVYX19.250.25
+1.32%
Jensen Quality Mid Cap Y
ACLAX17.440.19
+1.10%
American Century Mid Cap Value A
NWALX40.640.38
+0.94%
Nationwide BNY Mellon Dyn US Eq Inc A
FDWGX10.81-0.03
-0.28%
American Funds Dvlpg Wld Gr&Inc F3

ABCL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABCL has been loosely correlated with VCYT. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if ABCL jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABCL
1D Price
Change %
ABCL100%
+1.87%
VCYT - ABCL
56%
Loosely correlated
-0.66%
PRME - ABCL
55%
Loosely correlated
-0.67%
BEAM - ABCL
54%
Loosely correlated
-3.72%
ADPT - ABCL
53%
Loosely correlated
-1.13%
DNA - ABCL
53%
Loosely correlated
+3.62%
More

IGMS and

Correlation & Price change

A.I.dvisor indicates that over the last year, IGMS has been loosely correlated with MDGL. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if IGMS jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IGMS
1D Price
Change %
IGMS100%
-8.96%
MDGL - IGMS
42%
Loosely correlated
+3.83%
BTAI - IGMS
37%
Loosely correlated
-2.96%
ABCL - IGMS
37%
Loosely correlated
+1.87%
FATE - IGMS
35%
Loosely correlated
-6.76%
TNYA - IGMS
34%
Loosely correlated
-2.70%
More